Central Serous Chorioretinopathy

Retina: Fourth Edition

Volumn 2-3, Issue , 2005, Pages 1135-1161

  Klais, Christina M ^a   Ober, Michael D ^b   Ciardella, Antonio P ^c   Yannuzzi, Lawrence A ^d  

^a EAR AND THROAT HOSPITAL   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

^d VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84917282576     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-02598-0.50069-0     Document Type: Chapter

References (127)

1. von Graefe A Central recurrent retinitis. Graefes Arch Clin Exp Ophthalmol 1866, 12:211-215.
2. Bennet G Central serous retinopathy. Br J Ophthalmol 1955, 39:605-618.
3. Maumenee AE Symposium: Macular disease, clinical manifestations. Trans Pacific Coast Oto-Ophthalm Soc 1959, 40:139-160.
4. Gass JDM Stereoscopic atlas of macular diseases 1997, 49-70. CV Mosby, St. Louis. 4th edn.
5. Gass JDM Pathogenesis of disciform detachment of the neuro-epithelium. I. General concepts and classification. Am J Ophthalmol 1967, 63:573-585.
6. Gass JDM Pathogenesis of disciform detachment of the neuro-epithelium. II. Idiopathic central serous choroidopathy. Am J Ophthalmol 1967, 63:587-615.
7. Spaide RF, Campeas H, Haas L, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology 1996, 103:2070-2079.
8. Jalkh AE, Jabbour N, Avila MP, et al. Retinal pigment epithelial decompensation. I. Clinical features and natural course. Ophthalmology 1984, 91:1544-1548.
9. Polak BC, Baarasma GS, Snyers B Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 1995, 79:922-925.
10. de Venecia G. Fluorescein angiographic smoke stack. Verhoeff Society Meeting, Washington, DC, April 24-25, 1982. [Quoted from Gass JDM. Stereoscopic atlas of macular diseases. St. Louis: CV Mosby; 1987:56-57.].
11. Negi A, Marmor MF The resorption of subretinal fluid after diffuse damage of the retinal pigment epithelium. Invest Ophthalmol Vis Sci 1983, 24:1475-1479.
12. Negi A, Marmor MF Experimental serous retinal detachment and focal pigment epithelium damage. Arch Ophthalmol 1984, 102:445-449.
13. Marmor MF New hypotheses on the pathogenesis and treatment of serous retinal detachment. Graefes Arch Clin Exp Ophthalmol 1988, 226:548-552.
14. Spitznas M Pathogenesis of central serous retinopathy: a new working hypothesis. Graefes Arch Clin Exp Ophthalmol 1986, 224:321-324.
15. Spaide RF, Goldbaum M, Wong DWK, et al. Serous detachment of the retina. Retina 2003, 23:820-846.
16. Ciardella AP, Borodoker N, Costa DLL, et al. The expanding clinical spectrum of central serous chorioretinopathy. Comp Ophthalmol Update 2003, 4:71-84.
17. Guyer DR, Yannuzzi LA, Slakter JS, et al. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994, 112:1057-1062.
18. Prunte C, Flammer J Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996, 121:26-34.
19. Gelber GS, Schatz H Loss of vision due to central serous chorioretinopathy following psychological stress. Am J Psychiatry 1987, 144:46-50.
20. Yannuzzi LA Type-A behavior and central serous chorioretinopathy. Retina 1987, 7:111-130.
21. Horniker E Ueber eine Form von zentraler Retinitis auf angio-neurotischer Grundlage (Retinitis centralis angio-neurotica). Graefes Arch Clin Exp Ophthalmol 1929, 123:286-360.
22. Garg SP, Dada T, Talwar D, et al. Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol 1997, 81:962-964.
23. Bouzas EA, Scott MH, Mastorakos G, et al. Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 1993, 111:1929-1932.
24. Haimovici R, Koh S, Gagnon DR, et al. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 2004, 244-249. 111.
25. Gass JDM, Little HL Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology 1995, 102:737-747.
26. Friberg TR, Eller AW Serous retinal detachment resembling central serous chorioretinopathy following organ transplantation. Graefes Arch Clin Exp Ophthalmol 1990, 288:305-309.
27. Gass JDM Central serous chorioretinopathy and white subretinal exudation during pregnancy. Arch Ophthalmol 1991, 109:677-681.
28. Fastenburg DM, Ober RR Central serous choroidopathy in pregnancy. Arch Ophthalmol 1983, 101:1055-1058.
29. Quillen DA, Gass JDM, Brod R, et al. Central serous chorioretinopathy in women. Ophthalmology 1996, 103:72-79.
30. Tittl K, Spaide RF, Wong D, et al. Systemic and ocular findings in central serous chorioretinopathy. Am J Ophthalmol 1999, 128:63-68.
31. Yoshioka H, Sugita T, Nagayoski K Fluorescein angiography findings in experimental retinopathy produced by intravenous adrenaline injection. Folia Ophthalmol Jpn 1970, 21:648-652.
32. Yoshioka H, Katsume Y Experimental central serous chorioretinopathy. III: ultrstructural findings. Jpn J Ophthalmol 1982, 26:397-409.
33. Yoshioka H, Katsume Y, Akune H Experimental central serous chorioretinopathy in monkey eyes fluorescein angiographic findings. Ophthalmologica 1982, 185:168-178.
34. Miki T, Sunada I, Higaki T Studies on chorioretinitis induced in rabbits by stress (repeated administration of epinephrine). Acta Soc Ophthalmol Jpn 1972, 75:1037-1045.
35. Warren JB, Loi RK, Coughlan ML Involvement of nitric oxide in the delayed vasodilator response to ultraviolet light irradiation of rat skin in vivo. Br J Pharmacol 1993, 109:802-806.
36. Chrousos GP, Gold PW The concepts of stress and stress system disorders. Overview of physical and behavioral homeostatsis. JAMA 1992, 267:1244-1252.
37. Gill GN Adrenal gland. Best and Taylor's physiological basis of medical practice 1990, 820-830. Williams & Wilkins, Baltimore, MD. J.B. West (Ed.).
38. Smith TJ Dexamethasone regulation of glycosaminoglycan synthesis in cultured human skin fibroblast. Similar effects of glucocorticoid and thyroid hormones. J Clin Invest 1984, 74:2157-2163.
39. Ehrlich HP, Traver H, Hunt TK Effects of vitamin A upon inflammation and collagen synthesis. Ann Surg 1973, 177:222-227.
40. Pratt WB, Aronow L The effect of glucosteroids on protein and nucleic acid synthesis in mouse fibroblasts growing in vitro. J Biol Chem 1966, 241:5244-5250.
41. Yasuzumi T, Miki T, Sugimoto K Electromicroscopic studies of epinephrine choroiditis in rabbits. I. Pigment epithelium and Bruchs mmbrane in the healed stage. Nippon Ganka Gakkai Zasshi 1974, 78:588-598.
42. Basti CP Regulation of cation transport by low doses of glucocorticoids. J Clin Invest 1987, 80:848-856.
43. Sandle GI, McGlone F Acute effects of dexamethasone on cation transport in colonic epithelium. Gut 1987, 28:701-706.
44. + channels. Ann Rev Physiol 1991, 53:509-530.
45. Fine SL, Owens SL Central serous chorioretinopathy in a 7-year old girl. Am J Ophthalmol 1980, 90:871-873.
46. Klein ML, van Buskirk EM, Friedman E, et al. Experience with nontreatment of central serous choroidopathy. Arch Ophthalmol 1974, 91:247-250.
47. Leibowitz HM, Kreuger DE, Maunder LR, et al. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults. Surv Ophthalmol 1980, 24:335-610.
48. Spaide RF, Hall L, Haas A, et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996, 16:203-213.
49. Cordes FC A type of foveo-macular retinitis observed in the US Navy. Am J Ophthalmol 1944, 27:803-816.
50. Harrington DO The autonomic nervous system in ocular diseases. Am J Ophthalmol 1946, 29:1405-1425.
51. Werry H, Arends C Untersuchung zur Objektivierung von Persoenlichkeitsmerkmalen bei Patienten mit Retinopathia centralis serosa. Klin Monatsbl Augenheilkd 1978, 172:363-370.
52. Yannuzzi LA, Gitter KA, Schatz H Central serous chorioretinopathy. The macula: a comprehensive text and atlas 1979, 145-165. Williams & Wilkins, Baltimore, MD. L.A. Yannuzzi, K.A. Gitter, H. Schatz (Eds.).
53. Fukunaga K Central chorioretinopathy with disharmony of the autonomic nervous system. Acta Soc Ophthalmol Jpn 1969, 73:1468-1477.
54. Guyer DR, Gragoudas ES Central serous chorioretinopathy. Principles and practice of ophthalmology, vol. 2 1994, 818-825. WB Saunders, Philadelphia, PA. D.M. Albert, F.A. Jakobiec (Eds.).
55. Desai UR, Alhalel AA, Campen TJ, et al. Central serous chorioretinopathy in African Americans. J Natl Med Assoc 2003, 95:553-559.
56. Gass JDM Stereoscopic atlas of macular diseases: diagnosis and treatment 1997, 52-70. Mosby, St. Louis. 4th edn.
57. Jaeger WA, Nover A Stoerungen des Lichtsinns und Farbsinns bei Chorioretinitis centralis serosa. Graefes Arch Clin Exp Ophthalmol 1951, 52:11-120.
58. Frisén L, Frisén M Micropsia and visual acuity in macular edema. A study of neuroretinal basis of visual acuity. Graefes Arch Clin Exp Ophthalmol 1979, 210:69-77.
59. Bek T, Kandi M Quantitative anomaloscopy and optical coherence tomography scanning in central serous chorioretinopathy. Acta Ophthalmol Scand 2000, 78:632-637.
60. Klien BA Retinal lesions associated with uveal disease, part 1. Am J Ophthalmol 1956, 42:831-847.
61. Peyman GA, Bok D Peroxidase diffusion in the normal and laser-coagulated primate retina. Invest Ophthalmol Vis Sci 1972, 11:35-45.
62. Ie D, Yannuzzi LA, Spaide RF, et al. Subretinal exudative deposits in central serous chorioretinopathy. Br J Ophthalmol 1993, 77:349-353.
63. Schatz H, McDonald HR, Johnson RN, et al. Subretinal fibrosis in central serous chorioretinopathy. Ophthalmology 1995, 102:1077-1088.
64. Hooymans JM Fibrotic scar formation in central serous chorioretinopathy developed during systemic treatment with corticosteroids. Graefes Arch Clin Exp Ophthalmol 1998, 236:876-879.
65. Yannuzzi LA, Shakin JL, Fisher YL, et al. Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology 1984, 91:1554-1572.
66. Cohen D, Gaudric A, Coscas G, et al. Epitheliopathie retinienne diffuse et chorioretinopathie sereuse centrale. J Fr Ophtalmol 1983, 6:339-349.
67. Zweng HC, Little HL, Vassiliadis A Argon laser photocoagulation 1977, Mosby, St Louis.
68. Gass JDM Bullous retinal detachment: an unusual manifestation of idiopathic central serous choroidopathy. Am J Ophthalmol 1973, 75:810-821.
69. Nadel AJ, Turan MI, Coles RS Central serous retinopathy: a generalized disease of the pigment epithelium. Mod Probl Ophthalmol 1979, 20:76-88.
70. Gass JDM Photocoagulation treatment of idiopathic central serous choroidopathy. Trans Am Acad Ophthalmol Otolaryngol 1977, 83:456-463.
71. Schatz H, D'Oesterloh M, McDonald RH, et al. Development of retinal vascular leakage and cystoid macular edema secondary to central serous chorioretinopathy. Br J Ophthalmol 1993, 77:744-746.
72. Weiler W, Foerester MH, Wessing A Exudative retinal detachment, pigment epithelium tear, and subretinal exudate in a case of central serous chorioretinopathy. Klin Monatsbl Augenheilkd 1991, 199:450-453.
73. Iida T, Yannuzzi LA, Spaide RF, et al. Cystoid macular degeneration in chronic central serous chorioretinopathy. Retina 2003, 23:1-7.
74. Hilton AF, Harrison JD, Lamb AM, et al. Ocular complications in haemodialysis and renal transplant patients. Aust NZ J Ophthalmol 1982, 10:247-253.
75. Gass JDM, Slamovits TL, Fuller DG, et al. Posterior chorioretinopathy and retinal detachment after organ transplantation. Arch Ophthalmol 1992, 110:1717-1722.
76. Eckstein MB, Spalton DJ, Holder G Visual loss from central serous retinopathy in systemic lupus erythematosus. Br J Ophthalmol 1993, 77:607-609.
77. Haimovici R, Rumelt S, Melby J Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology 2003, 110:698-703.
78. Haimovici R, Gragoudas ES, Duker JS, et al. Central serous chorioretinopathy associated with inhaled or intranasal coricosteroids. Ophthalmology 1997, 104:1653-1660.
79. Wakakura M, Ishikawa S Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 1984, 68:329-331.
80. Iida T, Spaide RF, Negrao SG, et al. Central serous chorioretinopathy after epidural corticosteroid injection. Am J Ophthalmol 2001, 132:423-425.
81. Cohen SM, Kokame GT, Gass JDM Paraproteinemias associated with serous detachments of the retinal pigment epithelium and neurosensory retina. Retina 1996, 16:467-473.
82. Hassan L, Carvalho C, Yannuzzi LA, et al. Central serous chorioretinopathy in a patient using methylenedioxymethamphetamine (MDMA) or ecstasy. Retina 2001, 21:559-561.
83. Googe JM, Brady SE, Argyle JC, et al. Choroiditis in infantile periarteritis nodosa. Arch Ophthalmol 1985, 103:81-83.
84. Jampol LM, Lahav M, Albert DM, et al. Ocular clinical findings and basement membrane changes in Goodpasture's syndrome. Am J Ophthalmol 1975, 79:452-463.
85. Kihyoun JL, Kalina RE, Klein ML Choroidal involvement in systemic necrotizing vasculitis. Arch Ophthalmol 1987, 105:939-942.
86. Stropes LL, Luft FC Hypertensive crisis with bilateral bullous retinal detachment. JAMA 1977, 238:1948-1949.
87. Venecia G, Jampol LM The eye in accelerated hypertension. II. Localized serous detachments of the retina in patients. Arch Ophthalmol 1984, 102:68-73.
88. Gass JDM, Pautler SE Toxemia of pregnancy pigment epitheliopathy masquerading as heredomacular dystrophy. Trans Am Ophthalmol Soc 1985, 83:114-130.
89. Gitter KA, Houser BP, Sarin LK, et al. Toxemia of pregnancy: an angiographic interpretation of fundus changes. Arch Ophthalmol 1968, 80:449-454.
90. Menchini U, Lanzetta P, Virgili G, et al. Retinal pigment epithelium tear following toxemia of pregnancy. Eur J Ophthalmol 1995, 5:139-141.
91. Cogan DG Ocular involvement in disseminated intravascular coagulopathy. Arch Ophthalmol 1975, 93:1-8.
92. Spraul CW, Lang CE, Lang GK Central serous chorioretinopathy in systemic therapy with corticosteroids. Ophthalmology 1997, 94:392-396.
93. Spitznas M, Huke J Number, shape, and topography of leakage points in acute type I central serous chorioretinopathy. Br J Ophthalmol 1993, 77:349-353.
94. Shimizu K, Tobari I Central serous retinopathy dynamics of subretinal fluid. Mod Probl Ophthalmol 1971, 9:152-157.
95. Goldstein BG, Pavan PR "Blow outs" in the retinal pigment epithelium. Br J Ophthalmol 1987, 71:676-681.
96. Spitznas M, Hogan MJ Outer segments of photoreceptors and the retinal pigment epithelium: interrelationship in the human eye. Arch Ophthalmol 1970, 84:810-819.
97. Wessing A Grundsaetzliches zum diagnostischen Fortschritt durch die Fluoreszenzangiographie. Berl Dtsch Ophthalmol Ges 1973, 73:566-568.
98. Wessing A, Meyer-Schwickerath G Lichtchirurgische Behandlung und sonstige chirurgische Massnahmen. Berl Dtsch Ophthalmol Ges 1971, 73:585-593.
99. Levine R, Brucker AJ, Robinson F Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology 1989, 96:854-859.
100. Hayashi K, Hasegawa Y, Tokoro T Indocyanine green angiography of central serous chorioretinopathy. Int Ophthalmol 1986, 9:37-41.
101. Piccolino FC, Borgia L Central serous chorioretinopathy and indocyanine green angiography. Retina 1994, 14:231-242.
102. Giovannini A, Scasellati-Sforzolini B, D'Altobrando E Choroidal findings in the course of idiopathic serous pigment epithelium detachment detected by indocyanine green videoangiography. Retina 1997, 17:286-293.
103. Spaide RF, Orlock D, Herrmann-Delemazure B, et al. Wide-angle indocyanine green angiography. Retina 1998, 18:44-49.
104. Iida T, Kishi S, Hagimura N, et al. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 1999, 19:508-512.
105. Iida T, Spaide RF, Haas A, et al. Leopard-spot pattern of yellowish subretinal deposits in central serous chorioretinopathy. Arch Ophthalmol 2002, 120:37-42.
106. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991, 254:1178-1181.
107. Hee MR, Puliafito CA, Wong C, et al. Optical coherence tomography of central serous chorioretinopathy. Am J Ophthalmol 1995, 120:65-74.
108. Iida T, Hagimura N, Sato T, et al. Evaluation of central serous chorioretinopathy with optical coherence tomography. Am J Ophthalmol 2000, 129:16-20.
109. Ficker L, Vafadis G, While A, et al. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 1988, 72:829-834.
110. Yannuzzi LA, Ciardella A, Spaide RF, et al. The expanding spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 1997, 115:478-485.
111. Yannuzzi LA, Freund KB, Goldbaum M, et al. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology 2000, 107:767-777.
112. Spaide RF, Yannuzzi LA, Slakter JS, et al. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995, 15:100-110.
113. Watzke RC, Burton TC, Leaverton PA Ruby laser photocoagulation therapy of central serous retinopathy. Trans Am Acad Ophthalmol Otolaryngol 1974, 78:205-211.
114. Wessing A Changing concepts of central serous retinopathy and its treatment. Trans Am Acad Ophthalmol Otolaryngol 1973, 77:275-280.
115. L'Esperance FA Argon and ruby laser photocoagulation of disciform macular disease. Trans Am Acad Ophthalmol Otolaryngol 1971, 75:609-628.
116. Yap EY, Robertson DM The long-term outcome of central serous chorioretinopathy. Arch Ophthalmol 1996, 114:689-692.
117. Yannuzzi LA, Slakter JS, Kaufman SR, et al. Laser treatment of diffuse retinal pigment epitheliopathy. Eur J Ophthalmol 1992, 2:103-114.
118. Brancato R, Scialdone A, Pece A, et al. Eight-year follow-up of central serous chorioretinopathy with and without laser treatment. Graefes Arch Clin Exp Ophthalmol 1987, 225:166-168.
119. Castro-Correia J, Coutinho MF, Rosas V Long-term follow-up of central serous chorioretinopathy in 150 patients. Doc Ophthalmol 1992, 81:379-386.
120. Yannuzzi LA, Slakter JS, Gross NE, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy. Retina 2003, 23:288-298.
121. Chan WM, Lam DS, Lai TY, et al. Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin. Am J Ophthalmol 2003, 136:836-845.
122. Cardillo Piccolino F, Eandi CM, Ventre L, et al. Photodynamic therapy for chronic central serous chorioretinopathy. Retina 2003, 23:752-763.
123. Taban M, Boyer DS, Thomas EL, et al. Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 2004, 137:1073-1080.
124. Canakis C, Livir-Rallatos C, Panayiotis Z, et al. Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy. Am J Ophthalmol 2003, 136:750-752.
125. Faurschou S, Rosenberg T, Nielsen N Central serous retinopathy and presenile disciform macular degeneration. Acta Ophthalmol 1977, 55:515-524.
126. Schatz H, Yannuzzi LA, Gitter KA Subretinal neovascularization following argon laser photocoagulation treatment for central serous chorioretinopathy: complication or misdiagnosis?. Trans Am Acad Ophthalmol Otolaryngol 1977, 83:893-906.
127. Ergun E, Tittl M, Stur M Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy. Arch Ophthalmol 2004, 122:37-41.